Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Highlighted News

    Results (12)

    New vaccine platform promotes rare protective B cells

    New vaccine platform promotes rare protective B cells

    A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as HIV and influenza. Of particular interest are antibodies that are “broadly neutralizing,” meaning they can in principle eliminate multiple strains of a virus such as HIV, which mutates rapidly to evade the human immune system.Researchers at MIT and the Scripps Resear
    February 5, 2026
    Is this the new playbook for curing rare childhood diseases?

    Is this the new playbook for curing rare childhood diseases?

    “There is no treatment available for your son. We can’t do anything to help him.”When Fernando Goldsztein MBA ’03 heard those words, something inside him snapped.“I refused to accept what the doctors were saying. I transformed my fear into my greatest strength and started fighting.”Goldsztein’s 12-year-old son Frederico was diagnosed with relapsing medulloblastoma, a life-threatening pediatric bra
    January 24, 2025
    A new vaccine approach could help combat future coronavirus pandemics

    A new vaccine approach could help combat future coronavirus pandemics

    A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that could spill over from animals to humans.In addition to SARS-CoV-2, the virus that causes COVID-19, sarbecoviruses — a subgenus of coronaviruses — include the virus that led to the outbreak of the origi
    January 23, 2025
    A blueprint for better cancer immunotherapies

    A blueprint for better cancer immunotherapies

    Immune checkpoint blockade (ICB) therapies can be very effective against some cancers by helping the immune system recognize cancer cells that are masquerading as healthy cells. T cells are built to recognize specific pathogens or cancer cells, which they identify from the short fragments of proteins presented on their surface. These fragments are often referred to as antigens. Healthy cells will
    November 25, 2024
    A two-dose schedule could make HIV vaccines more effective

    A two-dose schedule could make HIV vaccines more effective

    One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines.Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over a two-week period could help overcome a part of that challenge by generating larger quantities of neutr
    September 20, 2024
    A new way to reprogram immune cells and direct them toward anti-tumor immunity

    A new way to reprogram immune cells and direct them toward anti-tumor immunity

    A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K. Shalek, and Darrell J. Irvine, in conjunction with a group at Georgia Tech led by M.G. Finn, has revealed a new strategy for enabling immune system mobilization against cancer cells. The work, which appears today in ACS Nano, produces exactly the type of anti-tumor immunity need
    September 16, 2024
    A snapshot of cancer vaccine development

    A snapshot of cancer vaccine development

    The road to effective cancer vaccines has been long and difficult.  Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccine would not emerge until about a century later, when Sipuleucel-T was used to treat prostate cancer in 2010. While the FDA-approved prostate cancer vaccine generated much excitement, its success has proven diffi
    August 15, 2023
    Putting the STING into cancer immunotherapy

    Putting the STING into cancer immunotherapy

    Immune checkpoint blockade therapies have been revolutionary in the treatment of some cancer types, emerging as one of the most promising treatments for diseases such as melanoma, colon cancer, and non-small cell lung cancer.  While in some cases checkpoint blockade therapies elicit a strong immune response that clears tumors, checkpoint inhibitors do not work for all tumor types or all patients.
    May 12, 2023
    Creating a versatile vaccine to take on Covid-19 in its many guises

    Creating a versatile vaccine to take on Covid-19 in its many guises

    One of the 12 labors of Hercules, according to ancient lore, was to destroy a nine-headed monster called the Hydra. The challenge was that when Hercules used his sword to chop off one of the monster’s heads, two would grow back in its place. He therefore needed an additional weapon, a torch, to vanquish his foe.There are parallels between this legend and our three-years-and-counting battle with SA
    March 9, 2023
    2022-23 Takeda Fellows: Leveraging AI to positively impact human health

    2022-23 Takeda Fellows: Leveraging AI to positively impact human health

    The MIT-Takeda Program, a collaboration between MIT’s School of Engineering and Takeda Pharmaceuticals Company, fuels the development and application of artificial intelligence capabilities to benefit human health and drug development. Part of the Abdul Latif Jameel Clinic for Machine Learning in Health, the program coalesces disparate disciplines, merges theory and practical implementation, combi
    January 12, 2023
    New 10-minute test detects Covid-19 immunity

    New 10-minute test detects Covid-19 immunity

    Researchers have successfully developed a rapid point-of-care test for the detection of SARS-CoV-2 neutralizing antibodies (NAbs). This simple test, only requiring a drop of blood from a fingertip, can be performed within 10 minutes without the need for a laboratory or specially trained personnel. Currently, no similar NAb tests are commercially available within Singapore or elsewhere.The work was
    November 22, 2021
    Accelerating the pace of engineered cell therapies, from lab to bedside

    Accelerating the pace of engineered cell therapies, from lab to bedside

    What if a cancer patient could receive life-saving cellular therapy within days of diagnosis rather than weeks? What if pharmaceutical researchers could bring new treatments to market in months rather than years?Kytopen is significantly speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms. The MIT spinout was co-founded by associate profes
    May 6, 2021
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.